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Successful attenuation of fearful memories is a cognitive process requiring initiation of
highly coordinated transcription programs. Chromatin-modulating mechanisms such as
DNA methylation and histone modifications, including acetylation, are key regulators of
these processes. However, knowledge concerning the role of ATP-dependent chromatin
remodeling factors (ChRFs) being required for successful fear extinction is lacking.
Underscoring the potential importance of these factors that alter histone-DNA contacts
within nucleosomes are recent genome-wide association studies linking several ChRFs
to various human cognitive and psychiatric disorders. To better understand the role of
ChRFs in the brain, and since to date little is known about ChRF expression in the
brain, we performed a comprehensive survey of expression levels of 24 ATP-dependent
remodelers across different brain areas, and we identified several distinct high molecular
weight complexes by chromatographic methods. We next aimed to gain novel insight
into the potential regulation of ChRFs in different brain regions in association with normal
and impaired fear extinction learning. To this end, we established the 129S1/SvImJ
(S1) laboratory mouse strain as a model for compromised contextual fear extinction
learning that can be rescued by dietary zinc restriction (ZnR). Using this model along
with genetically related but fear extinction-competent 129S6/SvEv (S6) mice as controls,
we found that impaired fear extinction in S1 was associated with enhanced ventral
hippocampal expression of CHD1 and reduced expression of CHD5 that was normalized
following successful rescue of impaired fear extinction. Moreover, a select reduction in
CHD3 expression was observed in the ventral hippocampus (vHC) following successful
rescue of fear extinction in S1 mice. Taken together, these data provide novel insight into
the regulation of specific ChRFs following an impaired cognitive process and its rescue,
and they suggest that imbalance of CHD-type remodeler levels, which consequently may
lead to changes of transcriptional programs, may be an underlying mechanism involved
in impaired fear extinction learning and its therapeutic rescue.
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INTRODUCTION
Anxiety and trauma-related disorders are the most prevalent
mental disorders in Western societies, with current estimates
suggesting that 30% of the population may be aﬄicted at
least once during their lifetime (Kessler et al., 2005; Wittchen
et al., 2011). These disorders including phobias, panic, and
posttraumatic stress disorder have an important learning
component and are often associated with impaired extinction
learning, the central mechanism for successful exposure-based
therapies (Bouton et al., 2001; Mineka and Zinbarg, 2006). In
recent years, it has become increasingly clear that mechanisms
that alter the structure and properties of chromatin, sometimes
broadly summarized by the term epigenetics, are key players in
the regulation of cognitive and emotional processes and thus also
of different aspects of fear acquisition, memory, and extinction
(reviewed e.g., in Jakovcevski and Akbarian, 2012; Dias et al.,
2013; Zovkic et al., 2013; Fischer, 2014; Rudenko and Tsai, 2014;
Whittle and Singewald, 2014).
Chromatin remodeling factors (ChRFs) are energy-dependent
molecular motor proteins that belong to the SNF2 protein
family and can be classified into 23 subgroups according to
sequence differences in their ATPase domains and the presence of
additional sequence motifs. In mammals, the best studied ChRF
subfamilies are the SWI/SNF (switch/sucrose non-fermenting),
ISWI (imitation switch), CHD (chromo helicase DNA binding),
and the INO80 (inositol auxotroph 80) subfamilies (Lusser
and Kadonaga, 2003; Marfella and Imbalzano, 2007; Clapier
and Cairns, 2009; Hargreaves and Crabtree, 2011; Piatti et al.,
2011). ChRFs use the energy derived from ATP hydrolysis to
disrupt and reform histone-DNA contacts. This activity can
result in diverse outcomes ranging from the repositioning of
nucleosomes along the DNA (sliding), to ejection and assembly
of nucleosomes or replacement of canonical with variant histones
(Clapier and Cairns, 2009). As a consequence, access to the
DNA for transcription factors and the transcription machinery
is enhanced or suppressed leading to activation or repression of
gene activity.
In contrast to other chromatin-regulatory mechanisms, such
as histone modifications or DNA methylation, ChRFs have been
given very little attention in brain research. Only recently, several
studies have uncovered genetic association of some ChRFs with
various intellectual and behavioral disorders (reviewed in Ronan
et al., 2013; Krumm et al., 2014; Vogel-Ciernia and Wood,
2014). Given that ChRFs are major regulators of chromatin and
transcriptional dynamics and therefore are likely to occupy a
central position in the regulation of transcriptional plasticity
required for all phases of learning and memory, a better
understanding of their role in brain function is highly desirable.
Thus, we conducted a broad survey of ChRF expression and
investigated their regulation following normal and impaired fear
extinction learning. Fear extinction dampens fear expression
in response to a conditioned stimulus (CS) or context that
no longer predicts aversive events. It is characterized by new
learning of a negative relationship between the CS or context
and the aversive event while the original fear memory is still
in place (reviewed in Johnson and Casey, 2015; Singewald
et al., 2015). Investigations into the molecular mechanisms
underlying impaired extinction and its therapeutic normalization
are important for the development of novel treatment strategies
for patients suffering from anxiety and trauma-related conditions
since deficient fear extinction can lead to prolonged anxiety
and result in stress and anxiety-related disorders. The laboratory
mouse strain 129S1/SvImJ (S1) constitutes a convenient model
for fear extinction studies as it exhibits compromised fear
extinction learning upon cued fear conditioning (Hefner et al.,
2008) that can be rescued by dietary zinc (Zn)-restriction
(Whittle et al., 2010). Since it was recently shown that the ATP-
dependent chromatin remodeling complex nBAF is involved in
contextual but not cued fear learning (Vogel-Ciernia et al., 2013),
we investigated here potential behavior-associated alterations in
ChRF expression levels in contextual fear extinction using S1
mice as well as the genetically related strain 129S6/SvEvTac (S6).
MATERIALS AND METHODS
Animals and Husbandry
Subjects were male 3-month-old 129S1/SvImJ (S1),
129S6/SvEvTac (S6) mice and C57BL/6 mice (obtained from
Charles River and Taconic, Germany) that were housed (4–5 per
cage) in a temperature- (22 ± 2◦C) and humidity- (50–60%)
controlled vivarium under a 12 h light/dark cycle (lights on at
7:00 a.m.). All experimental procedures were approved by the
Austrian Animal Experimentation Ethics Board.
Dietary Zinc Restriction (ZnR)
Animals were fed food pellets (ssniff Spezialdiäten) containing
low Zn (12.3mg/kg or 40% of the recommended daily intake
requirement; Reeves et al., 1993) or standard food pellets
containing normal quantities of Zn (65mg/kg) as previously
described (Whittle et al., 2010). Mice were fear conditioned
on standard diet before being placed on ZnR diet for 2 weeks
followed by fear expression or extinction training sessions.
General Procedures for Contextual Fear
Conditioning
An automated fear-conditioning system (TSE Systems, Bad
Homburg, Germany) was used for contextual fear conditioning.
Mice were conditioned in a 25 × 25 × 35 cm chamber with
transparent walls and a metal rod floor, cleaned with water and
illuminated to 300 lux (“context A”). After a 120 s acclimatization
period, mice received 2 s scrambled foot shock unconditioned
stimulus (US) (0.6mA) for three times with a 120 s inter-
trial interval. After the final US there was a 120 s no-stimulus
consolidation period beforemice were returned to the home cage.
Fear expression or extinction training was performed 14 days
later by re-exposing the mice to the conditioning context A for
4 or 16min, respectively. Freezing was measured as an index
of fear (Blanchard and Blanchard, 1969), manually scored based
on DVD recordings, defined as no visible movement except that
required for respiration, and converted to a percentage [(duration
of freezing within the context exposure/total time of the context
exposure)× 100] by a trained observer blind to the experimental
group.
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Statistical Analysis of Behavior
Experiments
The percentage of freezing is presented as mean± standard error
of the mean (SEM). Freezing levels during fear conditioning,
expression and extinction training were analyzed using multiple-
factor ANOVA with repeated-measures for trial, followed by a
Fisher LSD post-hoc analysis in case of significant interaction
effects. Level of statistical significance was set to P < 0.05.
Brain Dissections
Mice were sacrificed 2 h after fear expression or fear extinction
training and brains were removed. Amygdala, medial prefrontal
cortex (mPFC), dorsal (dHC), and ventral hippocampus (vHC)
of both hemispheres were dissected, weighed and snap frozen.
Where necessary, dissected regions from two to three animals
were pooled. Frozen tissue was stored at−80◦C.
RNA Isolation and qRT-PCR
Total RNA was isolated from different brain areas using Tri-
reagent (Sigma Aldrich) followed by DNaseI digestion and spin-
column clean-up (Zymo Research). Up to 5µg of RNA were
reverse-transcribed using the GoScript Reverse Transcription
System (Promega) according to the manufacturer’s instructions.
Real time PCR was performed in triplicate using POWER
SYBR Green PCR mastermix (Applied Biosystems) with 25 ng
cDNA and 0.4µM of target-specific primers. Primer sequences
are available upon request. Note that no amplification was
obtained for ERCC6, RAD54b, RAD54, and RAD54L2. Data
were normalized against Gapdh, 1CT values were centered at
the median and subjected to hierarchical clustering analysis using
Genesis software (Sturn et al., 2002).
Nuclear Extract Preparation
Frozen tissues were pulverized using the Cryoprep system
(Covaris) and resuspended in five volumes (v/w) homogenization
buffer (10mM Tris-HCl pH 7.9, 5mM MgCl2, 10mM KCl,
0.34M sucrose, 1× protease inhibitor cocktail (Roche), 0.1mM
PMSF, 1mM DTT). The homogenate was centrifuged for 10min
at 4◦C and 2000×g. The nuclear pellet was carefully resuspended
in two volumes (v/w) extraction buffer (15mM Tris-HCl pH
7.9, 0.25mM EDTA, 0.43M NaCl, 10% glycerol, 1× protease
inhibitor cocktail) and incubated on ice for 30min with gentle
mixing. Nuclear extract was obtained by centrifugation at
10,000×g for 30min at 4◦C.
Chromatography Procedures
Nuclear extract of six brains from 4-week-old male C57BL/6
mice was dialyzed against buffer CB (50mM Tris-HCl pH
7.9, 100mM NaCl, 5mM MgCl2, 1mM EDTA, 10% glycerol,
0.1mM PMSF, 1mM DTT) and loaded onto a 1ml Source15Q
anion exchange column (GE Healthcare) on an Äkta Explorer
FPLC system (GE Healthcare). After washing with 10 column
volumes (CV) buffer CB, proteins were eluted with a 15 CV
linear gradient from 100 to 500mM NaCl in buffer CB. 0.3ml
fractions were collected and subjected to immunoblotting using
antibodies against different ChRFs and HDACs. Source15Q
fractions containing peak amounts of the analyzed proteins (200–
280mM NaCl) were pooled, applied to a 100ml Superose 6
size exclusion column (GE Healthcare) and eluted with buffer
CB. Two milliliters fractions were collected and proteins were
precipitated by addition of 20% (final) trichloroacetic acid (TCA)
and incubation for 20min on ice. Precipitates were collected
by centrifugation at 17000×g for 15min, washed twice with
acetone, dried on ice and dissolved in 1× SDS loading buffer
(75mM Tris-HCl, pH 6.8, 0.6% SDS, 15% glycerol, and 1.075M
β-mercaptoethanol) for subsequent SDS-gel electrophoresis and
western blotting.
Immunoblotting
Proteins were separated by SDS-PAGE, transferred to
nitrocellulose membrane and incubated with antibodies
against CHD1 (Proteintech 20576-1-AP; 1:1000), CHD2 (Cell
Signaling 4170S; 1:500), CHD3 (Cell Signaling 4241S; 1:500;
Novus Biologicals NBP1-51593; 1:1000), CHD4 (Cell Signaling
4245S; 1:500), CHD5 (gift of Michael J. Pazin, HD5A-A Day 77;
Potts et al., 2011; 1: 15000), CHD7 (Santa Cruz Biotechnology sc-
79207; 1:1000), ATRX (Novus Biologicals NBP1-32851; 1:1000),
and Snf2H (Abcam AB3749; 1:500), HDAC1 (Zymed-Invitrogen,
34–8300), HDAC2 (Zymed-Invitrogen, No 34–6400), HDAC3
(Zymed-Invitrogen, 34-7700), and TBP (Millipore 05-1531;
1:250).
Quantification and Statistical Analysis
For relative quantification of protein amounts Image Studio
Lite software (LI-COR Biosciences) was used. Intensity values
were normalized against signals of TBP, which was used as
a loading control. For statistical evaluation GraphPad Prism
6.0 software (GraphPad Software, San Diego, CA, USA) was
used and Two-way ANOVA with Bonferroni’s post-hoc test was
applied.
Immunofluorescence Microscopy
Twelve weeks old male mice fed with standard food pellets
containing normal quantities of Zn (65mg/kg), were perfused
with 4% formaldehyde as described previously (Muigg et al.,
2009). Brains were quickly removed and postfixed at 4◦C
overnight in 4% paraformaldehyde in phosphate buffer and
sectioned. Coronal free-floating brain sections of 40µm
thickness were incubated for 30min in TBS (0.1M Tris-
HCl pH 7.4, 0.9% NaCl) with 1% H2O2, followed by three
washings with TBS. After incubation in 50% formamide/2xSSC
(300mM NaCl, 30mM sodium citrate tribasic, pH 7) for 2 h
at 65◦C, sections were washed twice in 2xSSC, treated with
2M HCl for 30min at 37◦C, washed in 0.1M borate buffer
(pH 8.5) for 10min followed by three washes in TBS. Samples
were blocked for 90min using 1% bovine serum albumin
(BSA) in TBS/0.1% Triton X-100 (TBST/1%BSA). Primary
antibody incubations were performed in TBST/1%BSA for 48 h
at 4◦C with gentle shaking. The following antibodies were
used: CHD3 (Novus Biologicals NBP1-51593; 1:1000), Satb2
(AbcamAB92446; 1:800), GABA (Sigma-Aldrich A2052; 1:7000).
Following three extensive washing steps with TBST/1%BSA,
secondary antibody (anti-mouse ALEXA647, Jackson Immuno
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Research 715-605-150; 1:500; anit-rabbit CY2, Jackson Immuno
Research 711-225-152; 1:500) in TBST/1%BSA was added for 2 h.
Sections were again washed 3 times, mounted on microscope
slides and dried overnight. ProLong Gold Antifade Mountant
with DAPI (Life Technologies P-36931) was applied and the
slides were cover-slipped. Microscopy was performed with an
Olympus BX51 fluorescence microscope equipped with UPlan
Apo 10×/0.40 and PlanApo 60×/1.42 oil immersion objectives.
Images were processed using cellSense dimension 1.5 software
(Olympus) and Adobe Photoshop CS3.
RESULTS
Characterization of ChRF Expression
Patterns and Complex Formation in the
Mouse Brain
To gain an initial overview of the expression of ChRFs
in the brain, we performed reverse-transcription qPCR
(RT-qPCR) analysis of 24 SNF2-type ATPases belonging
to all known mammalian subfamilies (Flaus et al., 2006)
from brain stem, cerebellum, midbrain, hypothalamus,
hippocampus/thalamus/septum, cortex, and olfactory bulb
regions (Figure 1A). Because it has been shown previously that
many ChRFs exhibit high expression in mouse embryonic stem
cells (ESCs; Efroni et al., 2008), RNA isolated from ESCs was
analyzed for comparison. Cluster analysis of median-centered
1CT values revealed two large expression groups (Figure 1B).
Group I shows overall higher expression in the brain than in
ESCs and comprises 13 ChRFs. CHD3, Brm, and CHD5 of this
group displayed the most pronounced enrichment in the brain
compared to ESCs. The expression levels of group II factors are
generally lower than those of group I in the brain but are similar
to the corresponding levels in ESCs. In addition, some factors
display specific expression patterns within the brain: for instance,
CHD7 is specifically overrepresented in the cerebellum, while
CHD5 is depleted from the cerebellum but slightly enriched in
the hypothalamus and the cortex; CHD6 is relatively depleted
in the hippocampus/thalamus/septum region and BTAF1 is
relatively enriched in the olfactory bulb (Figure 1B). With
respect to the spatial pattern of ChRF expression the data show
that transcript levels deviate most often in the cerebellum from
those of other brain regions (Figure 1B).
Next we sought to biochemically analyze ChRF complexes to
determine, if different ChRFs form distinct protein complexes
in the brain as has been reported for other tissues (Lusser
and Kadonaga, 2003; Clapier and Cairns, 2009; Becker and
Workman, 2013). In these experiments, we focused on factors
of the CHD-subfamily of ChRF (CHD1, CHD3, CHD5) and on
ATRX for the following reasons: (i) Antibodies against these
factors were commercially available and successfully detected
the corresponding proteins in brain protein extracts (Note:
we also tested antibodies against CHD2, CHD4, and CHD7
but obtained either no or very faint signals or signals that
did not correspond to the calculated size of the protein). (ii)
CHD3 and 5 show relatively high expression on the transcript
level enabling detection with limited tissue amount. (iii) All
these factors have been linked to brain development and/or
brain function before (Gaspar-Maia et al., 2009; Bérubé, 2011;
Nogami et al., 2011; Potts et al., 2011; Piatti et al., 2015).
High salt nuclear extracts were prepared from whole brains;
fractionated by Source 15Q anion exchange chromatography
and subjected to western blotting. CHD3 and CHD5 segregated
clearly from each other and the other two ChRFs in the salt
gradient elution, while CHD1 and ATRX coeluted at ∼270mM
NaCl (Supplementary Figure 1). To determine if the ChRFs
were contained in multisubunit complexes, peak fractions from
Source 15Q were pooled and applied to Superose 6 size exclusion
chromatography (SEC). CHD3, CHD5, and ATRX eluted with
peaks larger than the 660 kDa marker protein thyroglobulin
indicating that indeed high-molecular weight complexes are
present (Figure 1C). CHD1 signals were too faint after SEC
(despite concentration by TCA precipitation) to reliably obtain
any size information (data not shown). Since CHD3 and CHD5
are known to form complexes with HDACs in various tissues
(Tong et al., 1998; Wade et al., 1998; Xue et al., 1998; Zhang
et al., 1998; Potts et al., 2011), we also tested the elution patterns
of HDACs1, 2, and 3 on SEC. Signals corresponding to these
histone modifying proteins were detected in ChRF-containing
fractions. The elution profile of HDAC3 was relatively focused
and overlapped well with that of ATRX, CHD5, and CHD3.
The profiles of HDAC1 and HDAC2 were broader but still
overlapping (Figure 1C). Hence, the elution behavior of CHD3,
5, and ATRX in both anion exchange and SEC suggest that they
form distinct high molecular weight complexes in the mouse
brain that likely contain HDACs as previously reported for other
tissues.
S6 Mice Display Normal Fear Extinction
Learning Compared to Extinction-deficient
S1 Mice
Since the building of fear and fear extinction memories requires
considerable changes in the transcriptional program of specific
brain areas, such as the amygdala, the hippocampus, and the
prefrontal cortex (reviewed e.g., in Orsini and Maren, 2012), and
it is well known that ChRFs are heavily involved in regulating
gene expression at the transcriptional level (Marfella et al., 2006;
Hargreaves and Crabtree, 2011; Becker and Workman, 2013),
we hypothesized that ChRFs might be critical players in these
memory processes and that such a role might be reflected by
changes in the amounts of certain ChRFs during different stages
of extinction learning. To address this idea, we used two different
laboratory mouse strains: The 129S1/SvImJ (hereafter termed
S1) mouse strain has previously been shown to exhibit a severe
fear extinction deficit when subjected to cued fear conditioning
(Hefner et al., 2008). The second strain is the 129S6/SvEvTac
(hereafter termed S6) strain, which is closely related to the S1
strain and therefore suitable for comparisons on a molecular
level.
The first objectives of this experiment were to examine (i)
whether S6 mice show normal fear acquisition and extinction
behavior and (ii) whether S1 mice fail to attenuate context-
dependent fear expression similar to what has been shown before
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FIGURE 1 | mRNA expression and protein complex formation of various ChRFs in the brain and in embryonic stem cells (ESCs). (A) Schematic of regions
that were assessed for RNA levels of several ChRFs: Bs, brain stem; Ce, cerebellum; Mb, midbrain; Hth, hypothalamus; Hc, Th, S, hippocampus/thalamus/septum;
Ctx, cortex; and Ob, olfactory bulb. (B) ChRFs fall into two large expression groups (I + II) in the brain. RT-qPCR results were expressed as 1CT values (reference
gene: Gapdh) which were then centered at the median and subjected to hierarchical clustering. Red color indicates high expression (negative 1CT value) and green
color indicates low expression (positive 1CT value). (C) Superose 6 size exclusion chromatography of ChRF peak fractions after anion exchange chromatography
followed by immunoblot analysis of CHD3, CHD5, and ATRX as well as HDAC1, 2, and 3. The arrowhead indicates the void volume of the column, the asterisk marks
a scanning artifact. Molecular masses of defined marker proteins are indicated at the bottom of their corresponding elution fractions.
for cued conditioned fear (Hefner et al., 2008). The experimental
set-up is depicted in Figure 2A. During conditioning, all
experimental groups (n = 6/group) showed a significant increase
in freezing across conditioning trials [time (freezing to the
context) effect: F(3, 60) = 100.53, P < 0.001], which did not
differ between the strains [strain (S6 vs. S1) effect: F(1, 20) = 2.51,
P > 0.05] or groups [group (expression vs. extinction) effect:
F(1, 20) = 0.00019, P > 0.05]. During fear expression, S6 and
S1 mice displayed similar levels of freezing to the context [time×
strain effect: F(1, 10) = 0.41, P > 0.05; n = 6/group; Figure 2B].
During fear extinction training, there was a significant time ×
strain interaction for freezing [F(7, 63) = 8.29, P < 0.001;
n = 5−6/group; Figure 2B]. Post-hoc tests revealed that freezing
was significantly lower in S6 than in S1 mice starting after 8min
until the end of the experiment.
It has previously been shown that dietary zinc restriction
(ZnR) can successfully induce extinction learning in extinction-
impaired S1 mice following cued fear conditioning (Whittle
et al., 2010). Therefore, we assessed whether ZnR can also rescue
impaired extinction learning in S1 mice in a contextual fear
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FIGURE 2 | S1 mice exhibit compromised fear extinction upon contextual fear conditioning that can be rescued by dietary Zn restriction. (A) Schematic
of experimental design. During conditioning, performed in context A (gray box), mice receive 3 mild foot shocks (US) with 120 s non-stimulus intervals. After the final
US and a 120 s consolidation period, mice were returned to their home cages. They were either fed a control (Ctrl) or ZnR diet for 14 days before re-exposition to
context A and fear expression/extinction monitoring. (B–D) Freezing time index during conditioning, fear expression or fear extinction of S1 and S6 mice on Ctrl or
ZnR diet. Note, that fear expression and fear extinction, respectively, was tested on separate groups of animals (indicated by different symbols in the graph). Statistical
tests were performed comparing all experimental groups and conditions. To improve clarity, however, trend lines were distributed into three separate diagrams. Thus,
same-name data groups in (B–D) are identical. (B) S1 and S6 mice show a significant increase in freezing (n = 6/group; P < 0.001) during conditioning and similar
freezing levels during fear expression training (n = 6/group; P > 0.05). During fear extinction training, S1 mice displayed significantly higher freezing levels over time
than S6 mice (n = 5.6 per group; P < 0.001). (C) S1 mice on ZnR diet show a significant reduction of freezing compared to Ctrl-diet S1 mice (n = 5/group;
P < 0.001), while Zn restriction had no effect on fear expression. (D) Zinc restriction does not affect freezing of S6 during conditioning, fear expression and extinction
learning (P > 0.05; n = 6/group).
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conditioning paradigm (Figure 2C). Freezing levels increased
upon three US presentations regardless of group assignment
[time (freezing) effect: F(3, 60) = 100.78, P < 0.001; diet
(Ctrl fed vs. ZnR fed) effect: F(1, 20) = 0.04, P > 0.05;
group (expression vs. extinction) effect: F(1, 20) = 0.23, P >
0.05; n = 6/group] (Figure 2C). There was no difference
in freezing between Ctrl-fed and ZnR S1 mice during fear
expression [time × diet effect: F(1, 10) = 0.22, P > 0.05;
n = 6/group], and fear extinction training led to a significant
decline in freezing of ZnR S1 mice starting after 8min until
the end of the experiment [time × diet effect: F(7, 56) =
15.20, P < 0.001; n = 5/group] indicating successful fear
extinction, while high freezing levels persisted in Ctrl-fed S1 mice
(Figure 2C).
Dietary ZnR does not Affect Normal Fear
Extinction Learning in S6 Mice
We also examined the effects of ZnR on fear expression and
extinction in extinction-competent S6 mice following contextual
fear conditioning (Figure 2D). All groups (n = 6/group)
showed a similar increase in freezing to the context across US
presentations. This was ascertained from ANOVA results that
revealed a significant effect on freezing during conditioning of
conditioning trials [time (freezing to the context) effect: F(3, 60) =
116.72, P < 0.001], but not of diet [diet (Ctrl fed vs. ZnR fed)
effect: F(1, 20) = 1.90, P > 0.05] or group [group (expression
vs. extinction) effect: F(1, 20) = 0.10, P > 0.05]. During fear
expression, freezing did not differ between Ctrl and ZnR S6 mice
[time × diet effect: F(1, 10) = 0.49, P > 0.05; n = 6/group].
Moreover, ZnR did not further promote extinction learning in S6
mice during extinction training, as ANOVA revealed a significant
effect of time [F(7, 70) = 38.90, P < 0.001], but no significant
time–diet interaction [F(7, 70) = 0.79, P > 0.05].
Taken together these results demonstrate that S6 mice
display intact contextual fear expression and extinction
behavior. By contrast, S1 mice have a deficit in extinguishing
context-dependent fear and this deficit can be rescued by dietary
Zn restriction.
Fear Extinction Involves Specific Changes
in CHD1, CHD3, and CHD5 Protein Levels
We used S6, S1, and S1 animals rescued by ZnR diet to dissect
brain tissues 2 h after the end of the fear expression or extinction
training (Figure 2A) for nuclear protein extract preparation
and western blotting with antibodies against the ChRFs CHD1,
CHD3, CHD5, CHD7, ATRX, and SNF2h. Specifically, we
examined the following brain areas due to their importance
for fear learning and memory processes: the amygdala, dorsal
hippocampus (dHC), vHC, and the mPFC (Fanselow and
Dong, 2010; Marek et al., 2013; Wang et al., 2013; Johnson
and Casey, 2015; Singewald et al., 2015; Tovote et al., 2015).
While most tested ChRFs did not exhibit significant changes
in protein levels between fear expression and fear extinction
in the different brain regions and mouse strains (Table 1 and
data not shown), we observed significant behavior-dependent
regulation of protein levels of CHD1, CHD3, and CHD5
specifically in the vHC. CHD1, which is mostly known as a ChRF
regulating active transcription, was upregulated in extinction-
impaired S1 mice after unsuccessful extinction training (i.e.,
prolonged CS exposure). By contrast, when extinction training
was successful, such as in S6 and S1 ZnR mice, CHD1 amounts
did not vary between short (fear expression) and long (fear
extinction) CS exposure (Figure 3A and Table 1). Conversely,
the transcriptional co-repressor CHD3 remained unchanged
in non-extinguishing S1 mice, but was downregulated after
extinction training by 61% in behaviorally rescued S1 ZnR
mice. Likewise, a trend toward lower CHD3 amount (−39%,
P = 0.31) was observed in the vHC of extinction-competent
S6 animals following extinction training (Figure 3B, Table 1).
Finally, our analyses revealed that CHD5, which is closely related
to CHD3 and has predominantly been found as a repressor of
transcription, was downregulated by ∼30% (P = 0.014) in the
TABLE 1 | ChRF expression changes during fear extinction training in different brain areas of extinction-competent S6 and S1 ZnR mice and
extinction-deficient S1 mice.
Region ChRF S6 S1 S1-ZnR
Mean difference (%) P-value Mean difference (%) P-value Mean difference (%) P-value
vHC CHD1 −32.95 0.06 54.88 0.0003*** −2.49 >0.99
CHD5 −16.51 0.24 −30.06 0.035* −13.47 0.6737
CHD3 −38.55 0.31 11.17 >0.99 −60.66 0.021*
dHC CHD1 −27.88 0.56 −40.8 0.12 9.07 >0.99
CHD5 −37.68 0.38 −34.26 0.38 7.69 >0.99
SNF2H −24.00 0.53 −24.95 0.38 −21.32 0.57
Amy CHD1 9.236 >0.99 −20.59 0.85 39.36 0.14
mPFC CHD1 23.06 0.51 −22.01 0.82 9.81 >0.99
vHC, ventral hippocampus; dHC, dorsal hippocampus; Amy, amygdala; mPFC, medial prefrontal cortex. Negative values indicate a decrease.
*P < 0.05, ***P < 0.005.
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FIGURE 3 | S1 mice display behavior-dependent aberrant ChRF protein expression in the vHC. (A) CHD1 showed aberrant up-regulation (S6: n = 5; S1 and
S1 ZnR: n = 6), (B) CHD3 failed to become down-regulated (S6: n = 5; S1 and S1 ZnR: n = 6), and (C) CHD5 was down-regulated (S6: n = 5; S1: n = 4 and S1
ZnR: n = 3) following prologed CS exposure in the vHC of extinction-deficient S1 mice. Different brain areas were dissected from S6, S1 and S1 ZnR mice 2 h after
contextual fear expression or extinction training, nuclear proteins were extracted and subjected to western blot analysis with antibodies against different ChRFs.
Western blot signals were quantified, normalized to TBP and expressed relative to values of the respective fear expression group (left panels). Mean values ± SEM are
shown. Statistical significance of protein level differences was determined by Two-way ANOVA with Bonferroni’s post-hoc test (*P < 0.05; ***P < 0.005). Right panels,
representative western blots of significantly altered proteins are shown.
vHC of S1 mice after non-successful extinction training, while
protein levels did not change in extinction-competent S6 and
S1 ZnR mice (Figure 3C). Thus, the CHD-family remodelers
CHD1, CHD3, and CHD5 show marked deregulation in the
extinction-deficient S1 mice that is rescued along with the
behavioral defect by dietary restriction of zinc.
CHD3 Localizes to Excitatory and
Inhibitory Neurons in the Hippocampus
Since we have found fear behavior-related differences of
CHD1, CHD3, and CHD5 only in the vHC and not in
other examined areas, we next asked if these factors show
specific subcellular localization in the hippocampus. In a
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FIGURE 4 | CHD3 is expressed in all neuronal cell types of the hippocampus. Mouse brain sections were immunostained with antibodies against CHD3 (red),
Satb2 or GABA (green), and DNA was visualized by DAPI staining (blue). (A) CHD3-positive cells are found in all layers of the ventral hippocampus. CHD3 is highly
expressed in the dentate gyrus (DG), granulae cells and in the pyramidal cell layer of CA1-4. CHD3 colocalizes with Satb2-expressing excitatory neurons in the CA1.
(B) CHD3 is expressed in nuclei of Satb2-positive excitatory neurons. (C) Double staining for GABA and CHD3 in the vHC. (D) CHD3 is expressed by inhibitory
GABAergic neurons.
previous study, CHD5 was found to localize to neurons of
the hippocampus predominantly in the CA1-CA3 regions
but not to glia cells (Bergs et al., 2014). However, CHD1
and CHD3 localization in the hippocampus have not been
shown to date. Therefore, we performed immunofluorescence
stainings of hippocampal sections with antibodies against
CHD3, CHD1, and the excitatory neuron marker Satb2
(Huang et al., 2013) as well as the inhibitory neuron marker
GABA. Unfortunately, the CHD1 antibodies were not suitable
for tissue stainings regardless of the protocol used. By
contrast, robust signals were obtained with antibodies against
CHD3 in all nuclei of both the dorsal and vHC including
those of Satb2+ excitatory and GABA+ inhibitory neurons
(Figures 4A–D).
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DISCUSSION
ChRFs of the SNF2 family of ATPases are known to be involved
in the regulation of diverse mechanisms of DNA metabolism,
such as transcription, replication, nuclear architecture, or DNA
damage repair (Clapier and Cairns, 2009). While several ChRFs
have been studied in the context of brain development, research
regarding the role of ChRFs in cognitive and behavioral
functions is extremely sparse. The recent discovery of genetic
associations between several ChRFs (e.g., BAF complex, CHD8)
and intellectual and psychiatric disorders (Ronan et al., 2013;
Krumm et al., 2014; Vogel-Ciernia and Wood, 2014), however,
underscores the importance of understanding their specific roles
in the CNS. Therefore, we performed the first comprehensive
analysis of ChRF expression in the brain. The expression levels
of 24 members of SNF2-family remodelers revealed distinct
patterns for several factors in different brain areas. CHD3 and
BRM were the most highly expressed ChRFs in all brain regions,
and they exhibited clearly higher levels than in ESCs, which
are considered to be particularly enriched for ChRFs (Efroni
et al., 2008). BRM is one of the ATPase subunits of nBAF, a
neuron-specific chromatin remodeling complex that has recently
been implicated in learning and long-term memory formation
(Vogel-Ciernia et al., 2013). Its high expression throughout the
brain suggests possible functions in general brain physiology.
CHD3 is commonly found as part of a multiprotein complex
termed NuRD (Nucleosome Remodeling and Deacetylation)
which also contains the histone deacetylases HDAC1 and/or
HDAC2 (Denslow and Wade, 2007). Although it is currently not
known if CHD3 is part of a NuRD-like complex in the brain, we
now show that CHD3 is contained in a megadalton complex in
the brain that coelutes with HDAC1 and HDAC2 indicative of a
NuRD complex. Aside from the widespread expression of CHD3
mRNA in the brain, we detected the protein in Satb2+ excitatory
and GABA+ inhibitory neurons.
High expression levels throughout the brain were also
detected for CHD5. This protein is closely related to CHD3
and it was shown to be specifically expressed in mouse brain
and testes (Bergs et al., 2014). CHD5 is required for neuronal
differentiation during development (Egan et al., 2013) and acts
as a tumor suppressor in various cancers (Stanley et al., 2013).
Moreover, it was found to form a NuRD-like complex in the
brain predominantly containing HDAC2 over HDAC1 (Potts
et al., 2011). Our results are consistent with these previous
findings, since we also detected CHD5 in a megadalton complex
coeluting with HDAC2 in SEC as well as in anion exchange
chromatography. We further show that ATRX, another factor
that is highly expressed throughout the brain, also forms a high
molecular weight complex in brain nuclear extracts. ATRX is
recognized as a ChRF that localizes to heterochromatic regions
and interacts with a number of transcriptional co-repressors
(Ratnakumar and Bernstein, 2013). Mutations in the ATRX gene
were found to cause impaired contextual fear memory in mice
(Nogami et al., 2011) and α-Thalassaemia/mental Retardation
X-linked syndrome in humans (Gibbons et al., 1995). Although
in SEC, ATRX perfectly coelutes with HDAC3, the separation
profile on anion exchange chromatography argues against a
direct association between the two proteins. Taken together, we
have characterized the expression levels of most known ChRFs in
the brain and we have identified the existence of various high-
molecular weight ChRF complexes, including two NuRD-like
complexes containing either CHD3 or CHD5.
Aberrant ChRF Protein Levels Associated
with Impaired Contextual Fear Extinction
Our studies of ChRFs in the course of fear extinction learning
identified three CHD-type remodelers, CHD1, CHD3, and
CHD5, to exhibit aberrant protein levels in the extinction-
compromised S1 mouse model. Moreover, we found that these
changes are restricted to the vHC suggesting a particularly critical
role for CHD-type remodelers in this region in the contextual
fear extinction process. The role of the vHC in contextual fear
conditioning is not entirely clear. Unlike the dHC, the vHC
region is directly connected to the amygdala (Pitkänen et al.,
2000) and the mPFC (Laroche et al., 2000; Cenquizca and
Swanson, 2007; Tovote et al., 2015). Based on evidence from
several different studies, it has been suggested that the dorsal
hippocampal area is mainly responsible for spatial processing,
while the vHC mediates the expression of fear and extinction
via projections to the amygdala and the mPFC (Moser and
Moser, 1998; Bannerman et al., 2004; Fanselow and Dong,
2010). Importantly, inactivation of the vHC results in impaired
extinction of fear (Sierra-Mercado et al., 2011), and it typically
interferes with both cued and contextual fear conditioning
(Fanselow and Dong, 2010). The S1 mouse model used in this
study exhibits fully competent fear learning and expression in
response to either a tone stimulus (Hefner et al., 2008) or a
context stimulus (Figure 2), but is severely compromised in
fear extinction learning for both conditioned stimuli (Hefner
et al., 2008; Figure 2). The observed chromatin regulator changes
between expression and extinction in the vHC but in none of
the other tested areas (dHC, amygdala, mPFC) may suggest that
epigenetically balanced regulation of transcriptional programs
specifically in the vHC is particularly important for contextual
fear extinction learning.
We found that successful but not unsuccessful fear extinction
resulted in vHC-specific downregulation of CHD3. These data
are consistent with an earlier study in which downregulation
of CHD3 mRNA in the HC was found in extinction-competent
C57Bl/6 mice using a different contextual fear extinction
training protocol (Agis-Balboa et al., 2011). Furthermore,
successful fear extinction was found to be associated with
decreased levels of HDAC2, which is a partner of CHD3 in
the NuRD complex (Wei et al., 2012). NuRD is most often
linked to transcriptional repression. However, several studies
demonstrating its localization at large numbers of active genes
support the possibility that it might have activating as well
as repressing roles (Reynolds et al., 2012; Zhang et al., 2012).
The targeting of the NuRD complex to specific genes involves
interactions with specific transcription factors, such as Ikaros in
lymphoid cells or Cdk2ap1 in embryonic stem cells (Kim et al.,
1999; Deshpande et al., 2009). It is possible that behaviorally
successful fear extinction learning requires regulation of a
subset of CHD3-responsive genes in the vHC, which might
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be compromised in extinction-deficient S1 mice that show no
change of CHD3 levels in the course of unsuccessful extinction
training.
In contrast to CHD3, we found that unsuccessful extinction
training of S1 mice was associated with upregulation of
CHD1, which was not observed in extinction-competent S6 and
behaviorally rescued S1 mice. CHD1 is generally considered
to promote gene activation because it is mostly found at
transcriptionally active genes and interacts, for instance, with
elongation and splicing factors or the mediator complex (Lin
et al., 2011; Park et al., 2014; Siggens et al., 2015). On the
other hand, knock-down experiments in ESCs have shown that
more genes were upregulated in the absence of CHD1 (including
genes involved in neurogenesis) supporting repressive roles for
CHD1 (Gaspar-Maia et al., 2009). We have shown previously
that a CHD1 N-terminal mutant protein causes defects in ESC
differentiation leading to predominant neuronal differentiation
(Piatti et al., 2015). Although we show here that the overall
expression level of CHD1 in adult mouse brain is rather low, the
pronounced deregulation during unsuccessful extinction training
in the vHC of S1 suggests that locally and quantitatively restricted
expression of this remodeling factor may be important to enable
successful extinction learning.
While unsuccessful extinction training in S1 mice led to
increased CHD1 levels, the opposite was true for CHD5.
Although CHD5 has been shown to form a brain-specific NuRD-
like complex, and NuRD complexes are generally regarded as
transcriptional repressors, roughly equal numbers of genes were
up- and downregulated upon knock-down of CHD5 in primary
rat neurons (Potts et al., 2011). Interestingly, this study found
that upon CHD5 knock-down, genes classified under the GO
term “Behavioral fear response” failed to be upregulated to the
same extent over time in culture as observed in control cells.
Furthermore, Baf53b and other components of the neuronal
nBAF chromatin remodeling complex were upregulated in
CHD5 knock-down cells. Baf53b was recently shown to be
required for long-termmemory of contextual fear (Vogel-Ciernia
et al., 2013). In light of these and our data, it is likely that CHD5
is directly and/or indirectly via the nBAF complex involved in
the molecular regulation of fear behavior. Thus, it is tempting
to speculate that downregulation of CHD5 following impaired
fear extinction may result in unbalanced nBAF expression and
substantiation of fear memory.
Collectively, our data suggest a possible scenario for
the molecular functions of CHD1, CHD3, and CHD5 in
compromised fear extinction learning in S1 mice in that a subset
of genes that is regulated by CHD3 is not upregulated because
CHD3 levels do not decrease following impaired fear extinction.
Instead, different subsets of genes that are positively controlled
by CHD1 and/or negatively controlled by CHD5 might be
activated (e.g., nBAF) thus preventing fear extinction learning
andmemory. Future gene-expression profiling studies employing
the mouse models used in this study combined with brain area
specific knock-down of the remodeling factors will be necessary
to test these hypotheses. We provide here a first overview of
ChRF expression in mouse brain, and we show that CHD-type
remodelers are deregulated in a behavior-related manner during
contextual fear extinction in the extinction-deficient S1 mouse
model.
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